Richard Emmons


Richard is a partner on the U.S. intellectual property team.

He advises individual inventors, companies of all sizes, and academic institutions working in the life sciences, medical device, and mechanical art areas on various IP matters. Richard combines a strong entrepreneurial spirit, an extensive interdisciplinary research experience, and a deep knowledge of the law to counsel clients in the preparation and prosecution of U.S. and foreign patents in the life sciences, medical device, and mechanical art areas. He assists clients with IP due diligence, IP licensing, and patentability, infringement, validity, and freedom-to-operate analyses. His areas of expertise include protein and small molecule pharmaceuticals, antibody therapeutics, vaccines, gene therapy vehicles, constructs, and delivery systems, stem cell-based technologies, biological imaging, medical devices, microfluidics, and biofuels.

Richard has helped clients protect inventions involving protein, antibody, and small molecule therapeutics, mRNA- and protein-based vaccines, gene therapy (vehicles, constructs, and delivery systems), nutraceuticals, genetic engineering, genomics, tissue regeneration and organogenesis, stem cell-based technologies, model system screening assays for gene and drug discovery, nucleic acid – and protein chip-based technologies, bioinformatics analysis, nanobiotechnology, biological imaging, medical devices, microfluidics, and biofuels.

Richard has nearly two decades of research experience spanning developmental biology, genetics, epigenetics, microbiology, cell biology, and computational biology, which included a post-doctoral fellowship in the Department of Genetics at the Harvard Medical School that studied epigenetic mechanisms of gene regulation.

Track record





Performed a landscape analysis for a Fortune 500 company in the vaccine/LNP space.

Performed an IP diligence for a gene therapy company that helped the client obtain ~$75 million in early series financing.

Actively counsels clients on strategic management of complex patent portfolios related to medical device instruments.

State of Massachusetts

US Patent and Trademark Office

Patent Cases To Watch In 2022,’ Law360, January 3, 2022, quoted

Withers Launches Venture Capital and Life Sciences Team in Boston,’ Intellectual Property Magazine, April 20, 2021, featured

News Digest: On the Move,’ World Trademark Review, April 20, 2021, featured

Little Cumberland Island Wildlife Refuge, Board Member (2013-present)

Long Range Planning Committee, Member (1996-2006)

‘Life Sciences CEO Forum,’ December 2020, Boston, MA (presenter)

‘Patents 101: Protecting Innovations,’ December 2019, New Orleans, LA (presenter)

‘The World of Gene Therapy Intellectual Property,’ April 2018, Boston, MA (presenter)



  • English





Regularly works with...